Page last updated: 2024-09-04

carbapenems and Renal Insufficiency

carbapenems has been researched along with Renal Insufficiency in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (25.00)29.6817
2010's11 (68.75)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Chen, H; Yu, Z; Zhao, Y1
Bassetti, M; Carnelutti, A; Peghin, M; Righi, E1
Chusri, S; Doi, Y; Kositpantawong, N; Panthuwong, S; Singkhamanan, K; Suphasynth, Y; Wanitsuwan, W1
Changawala, N; Chapnick, E; Crusio, R; Kupfer, Y; Paul, V; Rao, S; Tiu, C; van Ginkel, J1
Amaya-Villar, R; Artero-González, ML; Bautista-Paloma, J; Corcia-Palomo, Y; Espejo-Gutiérrez de Tena, E; Garnacho-Montero, J; Gutiérrez-Pizarraya, A1
Ishibashi, T; Kubota, R; Matsuo, Y; Wajima, T1
Acikgoz, ZC; Guner, R; Guven, T; Izdes, S; Kocak Tufan, Z; Tasyaran, MA; Yilmaz, GR1
Goto, K; Hagiwara, S; Hidaka, S; Iwasaka, H; Noguchi, T1
Lin, R; Nandy, P; Samtani, MN1
Bogard, KN; Erwin, MW; Fuller, PD; Olsen, KM; Peterson, NT; Plumb, TJ1
Ben-Dov, IZ; Benenson, S; Bleumin, D; Bloch, A; Cohen, MJ; Esnault, VL; Haviv, YS; Levi, R; Mor-Yosef Levi, I; Moranne, O; Paltiel, O; Tzukert, K1
Chang, J; Chung, KS; Jung, JY; Kang, YA; Kim, EY; Kim, SK; Kim, SY; Kim, YS; Lee, SK; Lim, JE; Park, BH; Park, MS; Park, SC1
Aksungar, FB; Ozakkaş, F; Topkaya, AE; Tülbek, Y1
Costa, SF; Grinbaum, RS; Levin, AS; Oliveira, MS; Prado, GV1
Davies, BE; Kirkpatrick, C; Lennon, S; Liu, M; Luedin, E; Mallalieu, NL; Robson, R1
Horrevorts, AM; Mouton, JW; Touzw, DJ; Vinks, AA1

Reviews

3 review(s) available for carbapenems and Renal Insufficiency

ArticleYear
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?
    Seminars in respiratory and critical care medicine, 2017, Volume: 38, Issue:3

    Topics: Anti-Bacterial Agents; Bacteriological Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nebulizers and Vaporizers; Pneumonia; Pneumonia, Ventilator-Associated; Renal Insufficiency; Risk Factors

2017
Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients.
    Critical care medicine, 2011, Volume: 39, Issue:3

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Critical Care; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Linezolid; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Renal Insufficiency; Vancomycin

2011
Comparative pharmacokinetics of the carbapenems: clinical implications.
    Clinical pharmacokinetics, 2000, Volume: 39, Issue:3

    Topics: Carbapenems; Drug Interactions; Humans; Renal Insufficiency; Structure-Activity Relationship

2000

Trials

3 trial(s) available for carbapenems and Renal Insufficiency

ArticleYear
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult

2010
Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.
    Journal of Korean medical science, 2012, Volume: 27, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunocompromised Host; Intensive Care Units; Male; Middle Aged; Odds Ratio; Renal Insufficiency; Retrospective Studies; Risk Factors; Survival Rate; Time Factors

2012
Effect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Adult; Aged; Bacterial Infections; Carbapenems; Creatinine; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Renal Insufficiency

2008

Other Studies

10 other study(ies) available for carbapenems and Renal Insufficiency

ArticleYear
Trough concentration may not be a good target for polymyxin B therapeutic drug monitoring.
    Critical care (London, England), 2023, 01-25, Volume: 27, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Monitoring; Gram-Negative Bacteria; Humans; Polymyxin B; Renal Insufficiency

2023
Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumannii.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Carbapenems; Colistin; Drug Resistance, Microbial; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Postoperative Complications; Renal Insufficiency; Retrospective Studies; Tigecycline

2019
Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
    Scandinavian journal of infectious diseases, 2014, Volume: 46, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cohort Studies; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Polymyxin B; Prospective Studies; Renal Insufficiency; Rifampin; Survival Analysis; Treatment Outcome

2014
Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
    Chemotherapy, 2013, Volume: 59, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin

2013
Population pharmacokinetics of doripenem in Japanese subjects and Monte-Carlo simulation for patients with renal impairment.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Carbapenems; Computer Simulation; Doripenem; Humans; Japan; Middle Aged; Models, Biological; Models, Statistical; Monte Carlo Method; Renal Insufficiency; Young Adult

2015
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
    Journal of infection in developing countries, 2015, May-18, Volume: 9, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Renal Insufficiency; Retrospective Studies; Sulbactam; Treatment Outcome

2015
Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF).
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2010, Volume: 130, Issue:1

    Topics: Aged; Aged, 80 and over; Carbapenems; Critical Illness; Doripenem; Female; Half-Life; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Renal Insufficiency

2010
Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.
    The Journal of infection, 2012, Volume: 65, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Female; Follow-Up Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency; Risk Factors; Survival Analysis; Treatment Outcome

2012
[A case of urinary tract infection caused by Flavimonas oryzihabitans].
    Mikrobiyoloji bulteni, 2007, Volume: 41, Issue:1

    Topics: Anti-Infective Agents, Urinary; Bacteriuria; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Middle Aged; Ofloxacin; Pseudomonas; Pseudomonas Infections; Rectal Neoplasms; Renal Insufficiency; Urinary Tract Infections

2007
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:6

    Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ampicillin; APACHE; beta-Lactam Resistance; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Hospitals, Teaching; Humans; Infant; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymyxins; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam; Time Factors; Treatment Outcome

2008